Cardiology conferences | Cardiovascular Diseases conferences 2024 |Cardiology Conferences 2024 | CVDT 2024 | Cardiology events 2024 | cardiovascular Conferences | Paris

Cardiology Conferences , Cardiovascular diseases conferences, Cardiology meetings, Cardiology Meetings, Cardiology Events, Europe Cardiology Conferences, Therapeutics meetings, Cardiology Events, Cardiology Conferences, Cardiology Meetings, Therapeutics Conferences

Renowned Speakers

John M. Flack

Southern Illinois University School of Medicine, USA

Evgen Novikov

Amosov National Institute of Cardiovascular Surgery, Ukraine

Riccardo Cappato

Chief at IRCCS Humanitas Research Hospital, Italy

Volodymyr Popov

Amosov National Institute of Cardiovascular Surgery, Ukraine

Kate Tauber

Albany Medical Center, USA

Timothy F Christian

Albert Einstein College of Medicine, USA

Dipak P. Ramji

Professor School of Bioscience Cardiff University, UK

Kevin A. Courville

Prevail Heart Clinics, USA

Recommended Global Cardiology Webinars & Conferences

Europe & UK

Healthcare Summit 2024, UK CARDIOLOGY MEET 2024, France

Asia Pacific & Middle East

CARDIOLOGY MEETING-2024, UAE NEUROCOGNITIVE 2024, UAE PULMONOLOGY 2024, Singapore

Canada

Clinical-Trials-2024, Canada Dentistry World 2024, Canada

CVDT 2024

About conference

We extend a warm invitation to participants worldwide to join us for the Cardiovascular diseases and Therapeutics Conference, featuring insightful keynote presentations, engaging oral talks, informative poster presentations, and captivating exhibitions.

join us at the "7th International Conference on Cardiovascular Diseases and Therapeutics" set to take place in Paris, France on November 25-26, 2024. With the theme "Innovations in Cardiovascular Therapeutics: Personalized Approaches, Emerging Technologies”. our congress aims to Gather and Bringing together esteemed experts, researchers, scientists, and industry professionals from across the globe, the event facilitates the exchange of knowledge, sharing of insights, and collaboration towards preventing and treating cardiovascular diseases.

CVDT 2024 offers an exceptional global platform for cardiovascular health professionals through conferences, workshops, seminars, and B2B sessions, alongside interactive gatherings from diverse corners of the world. Join us as we collectively advance cardiovascular wellness and pave the way for enhanced heart health on a global scale.

why to Attend

Attending a Cardiovascular Diseases and Therapeutics Conference can offer numerous advantages, particularly if you’re involved in cardiovascular medicine or related fields. Here’s why it could be valuable:

Latest Research and Innovations: These conferences often showcase the latest research findings and technological advancements in cardiovascular diseases and treatments. Staying updated on cutting-edge research can enhance your practice and knowledge.
Networking Opportunities: It’s a prime opportunity to connect with peers, leading experts, and researchers in the field. Networking can lead to collaborations, mentorship opportunities, and professional relationships that can benefit your career.
Educational Workshops and Sessions: Conferences typically include workshops, panel discussions, and sessions that offer hands-on experience and in-depth learning about new techniques, therapies, and guidelines.
Professional Development: Attending can contribute to your professional development and continuing education credits, helping you stay current with your credentials and certifications.
Exposure to New Therapies and Technologies: You can learn about and interact with new drugs, devices, and technologies that are being introduced to the market, which can be crucial for providing the best care to your patients.
Interdisciplinary Insights: These conferences often feature a range of specialties, providing a holistic view of cardiovascular care and fostering a multidisciplinary approach to treatment.
Inspiration and Motivation: Engaging with passionate professionals and hearing about innovative approaches and success stories can reignite your enthusiasm and motivate you in your practice.

Target Audience

The target audience for a Cardiovascular Disease and Therapeutics Conference typically includes a diverse group of professionals involved in cardiovascular health and related fields. This audience may include:

Cardiologists
Cardiovascular Surgeons
Cardiovascular Researchers
Researchers and Scientists
Pharmacologists
Public Health care Professionals
Healthcare Administrators and Policy Maker
Medical and Healthcare Students
Industry Representatives
Electrophysiologists

sessions/Tracks

Track 1: Cardiology

Cardiology is the branch of medicine focused on the diagnosis, treatment, and management of heart conditions and diseases. It encompasses a broad range of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Cardiologists are medical professionals specializing in this field, working to improve cardiovascular health through a combination of clinical care, diagnostic testing, and therapeutic interventions

Track 2: Clinical cardiology

Clinical cardiology is a branch of cardiology that focuses on the diagnosis, management, and treatment of cardiovascular diseases in patients. It involves a hands-on, patient-centered approach to heart health, integrating clinical skills, diagnostic tools, and therapeutic interventions to address various heart conditions

Track 3: Cardiovascular diseases

Cardiovascular diseases (CVDs) encompass a broad range of conditions affecting the heart and blood vessels. They are a leading cause of morbidity and mortality worldwide.Understanding cardiovascular diseases involves recognizing the various types, their risk factors, symptoms, and management strategies. Early detection, effective treatment, and lifestyle modifications are key to improving outcomes and quality of life for individuals with cardiovascular conditions.

Track 4: Cardiovascular therapeutics

Cardiovascular therapeutics encompasses a broad range of treatments and interventions aimed at managing and curing diseases of the heart and blood vessels. The goal of these therapies is to improve cardiovascular health, alleviate symptoms, and reduce the risk of cardiovascular events such as heart attacks, strokes, and heart failure.

Track 5: Cardiac surgery

Cardiac surgery involves surgical procedures to treat diseases and conditions affecting the heart and blood vessels. These surgeries can be performed to correct structural heart problems, improve blood flow, or repair or replace damaged heart valves.

Track 6: Paediatric Cardiology

Pediatric cardiology is a specialized branch of cardiology focused on the diagnosis, treatment, and management of heart conditions in infants, children, and adolescents. Given the unique physiological and developmental aspects of pediatric patients, pediatric cardiology involves a tailored approach to managing congenital and acquired heart diseases in younger populations.

Track 7: Cardiac Pharmacology

Cardiac Pharmacology is a specialized branch of pharmacology that focuses on the study of drugs and therapeutic agents used to treat cardiovascular diseases. It encompasses the mechanisms, effects, and clinical applications of medications that target the heart and blood vessels.

Track 8: Pediatric vascular conditions

Pediatric vascular conditions encompass a range of disorders affecting the blood vessels in infants, children, and adolescents. Pediatric vascular conditions require careful evaluation and management to address both immediate and long-term needs. Advances in imaging and treatment techniques continue to improve outcomes and quality of life for affected children.

Track 9: Genetics and Vascular diseases

Genetics play a crucial role in the development of vascular diseases, influencing both congenital and acquired conditions. Understanding the genetic basis of vascular diseases can help in early diagnosis, personalized treatment, and risk assessment. Genetics plays a pivotal role in understanding and managing vascular diseases, offering insights into their causes and enabling more effective and personalized approaches to treatment. Advances in genetic research and technology continue to enhance our ability to diagnose, treat, and prevent vascular conditions.

Track 10: Cardiac Arrhythmias

Cardiac arrhythmias are disorders of the heart's rhythm or rate, resulting from problems with the electrical signals that coordinate heartbeats. These arrhythmias can range from benign to life-threatening and can affect both the heart's upper chambers (atria) and lower chambers (ventricles).

Cardiac arrhythmias represent a broad spectrum of conditions with varying degrees of severity and impact. Early diagnosis, appropriate management, and ongoing monitoring are essential for optimizing outcomes and improving quality of life for patients with arrhythmias.

Track 11:Cardiovascular Medicine

Cardiovascular medicine is a branch of medicine focused on the diagnosis, treatment, and management of diseases and conditions of the heart and blood vessels. It encompasses a broad range of topics, from coronary artery disease and heart failure to hypertension and arrhythmias.

Cardiovascular medicine is a dynamic and evolving field that integrates a variety of diagnostic, therapeutic, and preventive strategies to manage heart and vascular diseases. Advances in research and technology continue to improve patient outcomes and quality of life.

Track 12: Preventive Cardiology

Preventive cardiology focuses on reducing the risk of cardiovascular diseases (CVD) through proactive measures aimed at preventing their onset and progression. The goal is to manage risk factors, promote heart health, and ultimately reduce the incidence of heart attacks, strokes, and other cardiovascular events.

Preventive cardiology is a proactive approach to heart health that aims to reduce the incidence and impact of cardiovascular diseases through early intervention, lifestyle modifications, and ongoing risk management. By addressing risk factors and promoting heart-healthy behaviors, preventive cardiology helps improve overall cardiovascular health and quality of life.

Track 13: Congestive Heart Failure

Congestive Heart Failure (CHF) often referred to simply as heart failure, is a chronic and progressive condition in which the heart's ability to pump blood effectively is impaired. This leads to a build-up of fluid in the lungs and other tissues, causing a range of symptoms

Congestive Heart Failure is a complex condition requiring a comprehensive approach to management, including lifestyle changes, medical treatment, and potentially advanced interventions. Effective management aims to alleviate symptoms, improve heart function, and enhance overall quality of life for affected individuals

Track 14: Cardio Oncology

Cardio-oncology is an interdisciplinary field that focuses on the cardiovascular health of cancer patients and survivors. It addresses the cardiovascular risks associated with cancer treatments and the management of cardiovascular diseases in patients with cancer.

Cardio-oncology is a vital and evolving field that aims to improve the overall outcomes and quality of life for cancer patients by managing and mitigating cardiovascular risks associated with cancer and its treatments.

Track 15: Cardiovascular multimorbidity

Cardiovascular multimorbidity refers to the coexistence of multiple cardiovascular conditions in a single patient. This can include a range of disorders that affect the heart and blood vessels, leading to complex health challenges and requiring comprehensive management strategies.

Cardiovascular multimorbidity presents complex challenges that require a multifaceted and integrated approach to care. By addressing all coexisting conditions holistically, healthcare providers can improve outcomes, enhance quality of life, and reduce the burden of cardiovascular diseases.

Track 16: Hypertension

Hypertension, also known as high blood pressure, is a common but serious condition where the force of the blood against the walls of the arteries is consistently too high. This increased pressure can lead to various health complications, including cardiovascular diseases, stroke, and kidney damage.

Hypertension is a major public health issue with significant implications for overall health and quality of life. Effective management involves a combination of lifestyle changes, medications, and regular monitoring to prevent complications and improve patient outcomes.

Track 17: Diagnostic tests in cardiology

Diagnostic tests in cardiology are essential for assessing heart health, diagnosing cardiovascular conditions, and guiding treatment decisions. These diagnostic tests provide critical insights into heart health and are used to diagnose, evaluate, and manage a wide range of cardiovascular conditions. The choice of test depends on the clinical scenario, suspected diagnosis, and the specific information needed to guide treatment.

Track 18: Echocardiography

Echocardiography is a non-invasive imaging technique that uses ultrasound waves to create images of the heart. It provides detailed information about the heart’s structure and function, helping diagnose and monitor various cardiovascular conditions.

Echocardiography is a versatile and essential tool in cardiology, providing valuable insights into heart health and guiding clinical decision-making. Its ability to visualize the heart in real-time and assess various cardiac parameters makes it crucial for diagnosing and managing cardiovascular diseases.

Track 19: Heart Transplantation

Heart transplantation is a surgical procedure in which a diseased or damaged heart is replaced with a healthy donor heart. It is typically considered for patients with end-stage heart failure or severe heart conditions that cannot be managed with other treatments.

Heart transplantation remains a vital option for patients with severe heart conditions, offering the potential for improved survival and quality of life. It requires careful consideration of patient suitability, comprehensive preparation, and ongoing management to ensure the best outcomes.

Track 20: Geriatric Cardiology

Geriatric Cardiology focuses on the cardiovascular health of older adults. As people age, they often face unique cardiovascular challenges, including age-related changes in heart function and an increased risk of cardiovascular diseases. Geriatric cardiology is an evolving field that addresses the unique cardiovascular needs of older adults, emphasizing a holistic approach to managing heart health in the context of aging. It aims to improve outcomes and quality of life for elderly patients through tailored diagnostics, treatments, and comprehensive care strategies.

Track 21: Nephrocardiology

Nephrocardiology is an interdisciplinary field that focuses on the intersection between kidney and cardiovascular health. It addresses how chronic kidney disease (CKD) and cardiovascular diseases (CVD) are interrelated, and it aims to improve patient outcomes by integrating the management of these conditions.

Nephrocardiology plays a crucial role in managing the complex interactions between kidney and cardiovascular diseases. By addressing these interrelated conditions with a comprehensive, multidisciplinary approach, healthcare providers can improve patient outcomes and quality of life.

societies & associations

Attending a Cardiovascular Diseases and Therapeutics Conference often involves participation or association with several prominent societies and organizations that focus on cardiovascular health. These societies and associations play a key role in shaping the field through research, guidelines, education, and advocacy. Some notable ones include:

European Society of Cardiology (ESC)
European Association of Cardiothoracic Surgery (EACTS)
European Society of Hypertension (ESH)
European Society of Cardiac Radiology (ESCR)
European Society of Pediatric Cardiology (ESPC))
Heart Rhythm Society (HRS)
International Society for Heart and Lung Transplantation (ISHLT
Canadian Cardiovascular Society (CCS)
Society of Thoracic Surgeons (STS)
Asian Pacific Society of Cardiology (APSC)

Benefits of Participation

Advantages of Participating at our conference:

As an add on advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
Our robust online publicity attracts 20000+ users and 60000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
All the conference participants can earn up to 16-18 CME Credits by participating at our CVDT 2024 Conference scheduled on November 25-26, 2024 at Paris, France
To attain professional development we offer our participants a chance to earn up to 21 CPD Credits authorized by CPD Standards Office, UK by participating at our CVDT 2024 Conference.
All the conference participants will be awarded with IOCM Certification.
All the conference participants will have an unique opportunity to participate at One on One Meeting with Eminent Speakers
A Unique opportunity to hear what the global researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of CVDT 2024
Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
Thought provoking Symposia’s
Workshops on Carrier Development
Preconference workshops in all major countries
Nominations for Best Poster Award
Outstanding Young Researcher Award
Group Registration benefits

Awards & Opportunities

CVDT 2024 acknowledges participants for outstanding contributions to the field.

Awards Presented:

Young Scientist Award
Best Speaker Award
Best Poster Award
Best Keynote Speaker Award
Best Organizing Committee Member Award

Selection Criteria:

Overall abstract quality
Timeliness of the topic
Relevance to the conference scope and mission
Well-defined focus within the program track structure

Join us at CVDT 2024 by submitting your Abstract

To Collaborate Scientific Professionals around the World

Conference Date November 25-26, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

CVDT 2023 Conference

Supported By

Journal of Cardiac and Pulmonary Rehabilitation Cardiovascular Therapy: Open Access Journal of Medical Implants & Surgery

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Cardiovascular Diseases and Therapeutics

November 25-26, 2024 Paris, France

Innovations in Cardiovascular Therapeutics: Personalized Approaches and Emerging Technologies

Cardiology conferences | Cardiovascular Diseases conferences 2024 |Cardiology Conferences 2024 | CVDT 2024 | Cardiology events 2024 | cardiovascular Conferences | Paris | France |November 25-26, 2024

Conference Series Conferences gaining more Readers and Visitors